Jocelyn R. Grunwell

Jocelyn R. Grunwell

Auto-generated profile, based on publicly available information

Jocelyn R. Grunwell

Department of Pediatrics, School of Medicine, Emory University, Atlanta, GA, United States

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 1999 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
ADAshok A. Deniz
Ashok A. Deniz
MDMaxime Dahan
Maxime Dahan
JGJocelyn R. Grunwell
Jocelyn R. Grunwell
THTaekjip Ha
Taekjip Ha
AFAnn E. Faulhaber
Ann E. Faulhaber
PSPeter G. Schultz
Peter G. Schultz
Photon bursts from single diffusing donor-acceptor labeled macromolecules were used to measure intramolecular distances and identify subpopulations of freely diffusing macromolecules in a heterogeneous ensemble. By using DNA as a rigid spacer, a series of constructs with varying intramolecular donor-acceptor spacings were used to measure the mean and distribution width of fluorescence resonance energy transfer (FRET) efficiencies as a function of distance. The mean single-pair FRET efficiencies qualitatively follow the distance dependence predicted by Förster theory. Possible contributions to the widths of the FRET efficiency distributions are discussed, and potential applications in the study of biopolymer conformational dynamics are suggested. The ability to measure intramolecular (and intermolecular) distances for single molecules implies the ability to distinguish and monitor subpopulations of molecules in a mixture with different distances or conformational states. This is demonstrated by monitoring substrate and product subpopulations before and after a restriction endonuclease cleavage reaction. Distance measurements at single-molecule resolution also should facilitate the study of complex reactions such as biopolymer folding. To this end, the denaturation of a DNA hairpin was examined by using single-pair FRET.

1 December 1995 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
MMMilan Mrksich
Milan Mrksich
JGJocelyn R. Grunwell
Jocelyn R. Grunwell
GWGeorge M. Whitesides
George M. Whitesides

17 April 2001 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JGJocelyn R. Grunwell
Jocelyn R. Grunwell
JGJennifer L. Glass
Jennifer L. Glass
TLThilo D. Lacoste
Thilo D. Lacoste
ADAshok A. Deniz
Ashok A. Deniz
DCDaniel S. Chemla
Daniel S. Chemla
PSPeter G. Schultz
Peter G. Schultz

1 May 1997 in Tetrahedron Letters
Verified
Journal Article
Closed access
MSMiles G. Siegel
Miles G. Siegel
PHPatric J. Hahn
Patric J. Hahn
BDBruce A. Dressman
Bruce A. Dressman
JFJames E. Fritz
James E. Fritz
JGJocelyn R. Grunwell
Jocelyn R. Grunwell
SKStephen W. Kaldor
Stephen W. Kaldor

1 December 2016 in Pediatric Critical Care Medicine
Verified
Journal Article
Closed access
JGJocelyn R. Grunwell
Jocelyn R. Grunwell
CTCurtis Travers
Curtis Travers
CMCourtney E. McCracken
Courtney E. McCracken
PSPatricia D. Scherrer
Patricia D. Scherrer
ASAnne G. Stormorken
Anne G. Stormorken
PKPradip P. Md Kamat
Pradip P. Md Kamat
Objective: Most studies of ketamine administered to children for procedural sedation are limited to emergency department use. The objective of this study was to describe the practice of ketamine procedural sedation outside of the operating room and identify risk factors for adverse events.Design: Observational cohort review of data prospectively collected from 2007 to 2015 from the multicenter Pediatric Sedation Research Consortium.Setting: Sedation services from academic, community, free-standing children’s hospitals and pediatric wards within general hospitals.Patients: Children from birth to 21 years old or younger.Interventions: None.Measurements and Main Results: Describe patient characteristics, procedure type, and location of administration of ketamine procedural sedation. Analyze sedation-related adverse events and severe adverse events. Identify risk factors for adverse events using multivariable logistic regression. A total of 22,645 sedations performed using ketamine were analyzed. Median age was 60 months (range, < 1 mo to < 22 yr); 72.0% were American Society of Anesthesiologists-Physical Status less than III. The majority of sedations were performed in dedicated sedation or radiology units (64.6%). Anticholinergics, benzodiazepines, or propofol were coadministered in 19.8%, 57.9%, and 35.4%, respectively. The overall adverse event occurrence rate was 7.26% (95% CI, 6.92–7.60%), and the frequency of severe adverse events was 1.77% (95% CI, 1.60–1.94%). Procedures were not completed in 39 of 19,747 patients (0.2%). Three patients experienced cardiac arrest without death, all associated with laryngospasm.Conclusions: This is a description of a large prospectively collected dataset of pediatric ketamine administration predominantly outside of the operating room. The overall incidence of severe adverse events was low. Risk factors associated with increased odds of adverse events were as follows: cardiac and gastrointestinal disease, lower respiratory tract infection, and the coadministration of propofol and anticholinergics.

11 November 2021 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
JGJocelyn R. Grunwell
Jocelyn R. Grunwell
COCydney Opolka
Cydney Opolka
CMCarrie Mason
Carrie Mason
AFAnne M. Fitzpatrick
Anne M. Fitzpatrick